Cited 0 times in Scipus Cited Count

Blockade of quinolinic acid-induced neurotoxicity by pyruvate is associated with inhibition of glial activation in a model of Huntington's disease.

DC Field Value Language
dc.contributor.authorRyu, JK-
dc.contributor.authorKim, SU-
dc.contributor.authorMcLarnon, JG-
dc.date.accessioned2011-07-15T02:20:17Z-
dc.date.available2011-07-15T02:20:17Z-
dc.date.issued2004-
dc.identifier.issn0014-4886-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/3372-
dc.description.abstractIn this study, we have examined the mechanisms involved in pyruvate-mediated neuroprotection against quinolinic acid (QA)-induced striatal damage. QA injection into the striatum caused widespread neuronal damage and extensive areas of lesions in core and penumbra. The involvement of oxidative-mediated striatal damage was suggested by increased expressions of peroxynitrite, marked lipid peroxidation, and formation of DNA oxidative damage products. Administration of pyruvate, a glycolysis end product with antioxidant activity, significantly reduced QA-mediated striatal lesions, neuronal degeneration, and oxidative damage, whereas another energy substrate, lactate, was ineffective against oxidative damage and only partially effective in reducing lesions and neuronal degeneration. Treatment with the iNOS inhibitor aminoguanidine attenuated QA-mediated striatal lesions and reduced oxidative damage, indicating that iNOS activation may be involved in the striatal oxidative damage induced by QA. A role for glial cells in mediating oxidative damage was suggested because pyruvate blocked the expression of iNOS and nitrotyrosine in activated microglia and astrocytes in QA-injected striatum. These data suggest that pyruvate reduces oxidative free radical damage in QA-injected striatum and could have clinical utility in the treatment of Huntington's disease (HD).-
dc.language.isoen-
dc.subject.MESHAnimals-
dc.subject.MESHDisease Models, Animal-
dc.subject.MESHDrug Administration Routes-
dc.subject.MESHEnzyme Inhibitors-
dc.subject.MESHGuanidines-
dc.subject.MESHHuntington Disease-
dc.subject.MESHLactic Acid-
dc.subject.MESHMale-
dc.subject.MESHNeostriatum-
dc.subject.MESHNeuroglia-
dc.subject.MESHNeuroprotective Agents-
dc.subject.MESHNitric Oxide Synthase-
dc.subject.MESHNitric Oxide Synthase Type II-
dc.subject.MESHOxidative Stress-
dc.subject.MESHPyruvic Acid-
dc.subject.MESHQuinolinic Acid-
dc.subject.MESHRats-
dc.subject.MESHRats, Sprague-Dawley-
dc.subject.MESHStereotaxic Techniques-
dc.subject.MESHTyrosine-
dc.titleBlockade of quinolinic acid-induced neurotoxicity by pyruvate is associated with inhibition of glial activation in a model of Huntington's disease.-
dc.typeArticle-
dc.identifier.pmid15081596-
dc.identifier.urlhttp://linkinghub.elsevier.com/retrieve/pii/S0014488604000147-
dc.contributor.affiliatedAuthor김, 승업-
dc.type.localJournal Papers-
dc.identifier.doi10.1016/j.expneurol.2004.01.006-
dc.citation.titleExperimental neurology-
dc.citation.volume187-
dc.citation.number1-
dc.citation.date2004-
dc.citation.startPage150-
dc.citation.endPage159-
dc.identifier.bibliographicCitationExperimental neurology, 187(1). : 150-159, 2004-
dc.identifier.eissn1090-2430-
dc.relation.journalidJ000144886-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Neurology
Files in This Item:
There are no files associated with this item.

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse